DOCSLIB.ORG

Catalog Probe Sets QG Viewrna ISH Cell Assay (2).Xlsx

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Catalog Probe Sets QG Viewrna ISH Cell Assay (2).Xlsx Gene Symbol Gene Name Accession Species Catalog Number Probe Set Type Wavelenght 18S 18S ribosomal X03205 human/rat/mouse VA1-10188 TYPE1 550 18s-Negative 18s-Negative X03205_N human/rat/mouse VF1-10147 TYPE1 550 1A 1A EU370653 hepatitis c virus VF1-11209 TYPE1 550 1B 1B AJ238799.2 hepatitis c virus VF1-11210 TYPE1 550 2410004A20Rik RIKEN cDNA 2410004A20 gene NM_025890 mouse VB1-10633 TYPE1 550 ABCA1 ATP-binding cassette, sub-family A (ABNM_005502 human VA1-10160 TYPE1 550 Abca1 ATP-binding cassette, sub-family A (ABNM_013454 mouse VB6-11118 TYPE6 650 ABCA1 ATP-binding cassette, sub-family A (ABNM_005502 human VA6-11119 TYPE6 650 Abcb1 ATP-binding cassette, sub-family B (MDNM_001003215 dog VF1-10960 TYPE1 550 ABL1 v-abl Abelson murine leukemia viral onNM_005157 human VA1-10096 TYPE1 550 ABL1 v-abl Abelson murine leukemia viral onNM_005157 human VA6-10828 TYPE6 650 ACP5 acid phosphatase 5, tartrate resistant NM_001611 human VA1-10348 TYPE1 550 ACTA2 actin, alpha, smooth muscle, aorta NM_001613 human VA1-10300 TYPE1 550 ACTB actin, beta NM_001101 human VA4-10293 TYPE4 488 ACTB actin, beta NM_007393 mouse VB4-10432 TYPE4 488 ACTB actin, beta AB004047 green monkey VF1-10226 TYPE1 550 ACTB actin, beta NM_007393 mouse VB1-10350 TYPE1 550 ACTB actin, beta DQ845171 sus scrofa VF1-10223 TYPE1 550 ACTB actin, beta NM_031144 rat VC1-10172 TYPE1 550 ACTB actin, beta DQ657949 mosquito VF1-10224 TYPE1 550 ACTB actin, beta NM_001033084 macaca mulatta VF1-10424 TYPE1 550 ACTB actin, beta NM_001101 human VA1-10351 TYPE1 550 ACTB actin, beta NM_031144 rat VC6-10831 TYPE6 650 ACTB actin, beta NM_001101 human VA6-10506 TYPE6 650 ACTB actin, beta NM_001101 human VA10-10504 TYPE10 740 ACTG2 actin, gamma 2, smooth muscle, enterNM_001615 human VA1-10437 TYPE1 550 ADCY5 adenylate cyclase 5 NM_022600 rat VC6-10989 TYPE6 650 ADCY8 novel protein similar to vertebrate ade NM_001143752 zebrafish VF1-10195 TYPE1 550 ADIPOR1 adiponectin receptor 1 NM_015999 human VA1-10377 TYPE1 550 ADIPOR2 adiponectin receptor 2 NM_024551 human VA1-10376 TYPE1 550 Adora2a adenosine A2a receptor NM_053294 rat VC6-11075 TYPE6 650 ADRA1A adrenergic, alpha-1A-, receptor NM_000680 human VA1-10215 TYPE1 550 ADRA1A-Negative adrenergic, alpha-1A-, receptor NM_000680-N human VA1-10438 TYPE1 550 ADRA1B adrenergic, alpha-1B-, receptor NM_000679 human VA1-10532 TYPE1 550 ADRA1D adrenergic, alpha-1D-, receptor NM_000678 human VA1-10531 TYPE1 550 AGC1 aggrecan1 NM_001135 human VA1-10451 TYPE1 550 Agpt2 angiopoietin 2 NM_007426 mouse VB1-10230 TYPE1 550 AHSA1 AHA1, activator of heat shock 90kDa p NM_012111 human VA1-10243 TYPE1 550 Aif1 allograft inflammatory factor 1 NM_019467 mouse VB1-10634 TYPE1 550 ALK anaplastic lymphoma kinase (Ki-1) NM_004304 human VA1-10625 TYPE1 550 ALK anaplastic lymphoma kinase (Ki-1) NM_004304 human VA10-10590 TYPE10 740 ALR ALR K00901 human VA1-11019 TYPE1 550 ALR-Negative ALR-Negative K00901_N human VA1-11018 TYPE1 550 AMACR Alpha-methylacyl-CoA racemase NM_014324 human VA4-10722 TYPE4 488 AMACR Alpha-methylacyl-CoA racemase NM_014324 human VA1-10723 TYPE1 550 ANLN anillin, actin binding protein NM_018685 human VA1-10344 TYPE1 550 APOA1 apolipoprotein A-1 NM_000039 human VA1-10349 TYPE1 550 APO b apolipoprotein B NM_009693 mouse VB1-10210 TYPE1 550 APO b apolipoprotein B (including Ag(x) antig NM_000384 human VA10-10298 TYPE10 740 APO e apolipoprotein E NM_009696 mouse VB1-10244 TYPE1 550 Aqp1 aquaporin 1 NM_012778 rat VC1-11190 TYPE1 550 Aqp2 aquaporin 2 NM_012909 rat VC1-10819 TYPE1 550 Aqp2 aquaporin 2 (collecting duct) XM_543678 dog VF1-11163 TYPE1 550 AR androgen Receptor NM_000044 human VA4-11155 TYPE4 488 AR androgen Receptor NM_000044 human VA1-10616 TYPE1 550 Arbp acidic ribosomal phosphoprotein P0 NM_022402 rat VC1-10192 TYPE1 550 Arbp acidic ribosomal phosphoprotein P0 NM_022402 rat VC6-11174 TYPE6 650 Arc activity regulated cytoskeletal-associatNM_018790 mouse VB1-10454 TYPE1 550 Arc activity regulated cytoskeletal-associatNM_019361 rat VC1-10086 TYPE1 550 Arc-Negative activity regulated cytoskeletal-associatNM_019361_N rat VC1-10152 TYPE1 550 ARPC2 actin related protein 2/3 complex, subuNM_005731 human VA1-11031 TYPE1 550 ATG12 ATG12 autophagy related 12 homolog NM_004707 human VA1-10047 TYPE1 550 ATP6 mitochondiral ATP6 NC_004030 sea lion VF1-10738 TYPE1 550 Avp arginine vasopressin NM_016992 rat VC1-10031 TYPE1 550 AXIN2 axin2 NM_015732 mouse VB1-10588 TYPE1 550 AXIN2 axin 2 (conductin, axil) NM_004655 human VA1-10388 TYPE1 550 B2M beta 2-microglobulin X57112 cricetulus griseus VF4-10952 TYPE4 488 B2M beta 2-microglobulin NM_009735 mouse VB1-11142 TYPE1 550 B2M beta 2-microglobulin NM_004048 human VA1-10611 TYPE1 550 B2M beta 2-microglobulin NM_004048 human VA10-10297 TYPE10 740 B2M beta 2-microglobulin NM_009735 mouse VB10-10292 TYPE10 740 Bace beta-site APP-cleaving enzyme NM_011792 mouse VB1-10237 TYPE1 550 BCL2 B-cell CLL/lymphoma 2 NM_000633 human VA1-10189 TYPE1 550 BCL2L10 BCL2-like 10 (apoptosis facilitator) NM_020396 human VA1-10206 TYPE1 550 BCL2L11 BCL2-like 11 (apoptosis facilitator) NM_006538 human VA1-10816 TYPE1 550 BCL6 B-cell CLL/lymphoma 6 NM_001706 human VA1-11134 TYPE1 550 Gene Symbol Gene Name Accession Species Catalog Number Probe Set Type Wavelenght BCR breakpoint cluster region NM_004327 human VA10-10829 TYPE10 740 Bdkrb1 bradykinin receptor B1 NM_030851 rat VC1-11130 TYPE1 550 BDKRB1 bradykinin receptor B1 NM_000710 human VA1-11131 TYPE1 550 Bdnf brain derived neurotrophic factor NM_007540 mouse VB1-10810 TYPE1 550 BDNF brain-derived neurotrophic factor NM_170731 human VA1-10184 TYPE1 550 Beta-actin beta actin AF012125 salmon VF1-10225 TYPE1 550 BIRC5 baculoviral IAP repeat-containing 5 (suNM_001168 human VA1-11137 TYPE1 550 BIRC5_Negative baculoviral IAP repeat-containing 5 NM_001168_N human VA1-10867 TYPE1 550 BLM bloom syndrome NM_000057 human VA1-10010 TYPE1 550 Bmi1 B lymphoma Mo-MLV insertion region 1NM_007552 mouse VB1-10883 TYPE1 550 BMP2 bone morphogenetic protein 2 NM_001200 human VA1-10479 TYPE1 550 BMP6 bone morphogenetic protein 6 NM_001718 human VA1-10159 TYPE1 550 Bmp7 bone morphogenetic protein 7 NM_001191856 rat VC1-11108 TYPE1 550 BRAF v-raf murine sarcoma viral oncogene hNM_004333 human VA1-11135 TYPE1 550 BRLF1 BRLF1 AJ507799 human herpes virus 4VF1-11097 TYPE1 550 BRRN1 barren homolog (Drosophila) NM_015341 human VA1-10345 TYPE1 550 Bsn bassoon NM_019146 rat VC6-10993 TYPE6 650 BTG2 BTG family, member 2 NM_006763 human VA1-10128 TYPE1 550 BZLF1 BZLF1 AJ507799.2 human herpes virus 4VF1-11197 TYPE1 550 CA1 carbonic anhydrase I NM_001738 human VA1-10052 TYPE1 550 CA2 carbonic anhydrase II NM_000067 human VA1-10078 TYPE1 550 Cacna1i calcium channel, voltage-dependent, T NM_020084 rat VC6-10991 TYPE6 650 Cacng2 calcium channel, voltage-dependent, g NM_053351 rat VC6-10979 TYPE6 650 Calb1 calbindin 1, 28kDa XM_848991 dog VF1-11161 TYPE1 550 Calb1 calbindin 1 NM_031984 rat VC6-10983 TYPE6 650 Calca calcitonin/calcitonin-related polypeptid NM_017338 rat VC4-10850 TYPE4 488 Calca calcitonin-related polypeptide alpha NM_001741 human VA1-10304 TYPE1 550 Calca calcitonin/calcitonin-related polypeptid NM_007587 mouse VB1-10936 TYPE1 550 Calca calcitonin/calcitonin-related polypeptid NM_017338 rat VC1-10306 TYPE1 550 Calca calcitonin/calcitonin-related polypeptid NM_017338 rat VC10-10472 TYPE10 740 Calcb calcitonin-related polypeptide, beta NM_138513 rat VC1-11128 TYPE1 550 calcr calcitonin receptor NM_001742 human VA1-10303 TYPE1 550 Calcr calcitonin receptor NM_053816 rat VC1-10305 TYPE1 550 Calcr calcitonin receptor NM_053816 rat VC6-10849 TYPE6 650 Calcr calcitonin receptor NM_001742 human VA6-10837 TYPE6 650 Calcrl calcitonin receptor-like NM_012717 rat VC1-10937 TYPE1 550 Calcrl calcitonin receptor-like NM_005795 human VA1-10938 TYPE1 550 Camk1d calcium/calmodulin-dependent protein NM_177343 mouse VB1-10436 TYPE1 550 Camk2a calcium/calmodulin-dependent protein NM_012920 rat VC10-10542 TYPE10 740 Camkk2 calcium/calmodulin-dependent protein NM_031338 rat VC6-10985 TYPE6 650 CAV1 caveolin 1, caveolae protein, 22kDa NM_001753 human VA4-10815 TYPE4 488 CAV1 caveolin 1, caveolae protein, 22kDa NM_001753 human VA1-10205 TYPE1 550 CAV2 Caveolin 2 NM_001233 human VA4-10814 TYPE4 488 Ccl2 chemokine (C-C motif) ligand 2 NM_031530 rat VC1-11022 TYPE1 550 Ccl3 chemokine (C-C motif) ligand 3 NM_002982 human VA1-11041 TYPE1 550 Ccl28 chemokine (C-C motif) ligand 28 NM_020279 mouse VB1-11017 TYPE1 550 Ccl3 chemokine (C-C motif) ligand 3 NM_002983 human VA4-10821 TYPE4 488 Ccnb1 cyclin B1 NM_172301 mouse VB4-10316 TYPE4 488 Ccnb2 cyclin B1 NM_031966 human VA1-10369 TYPE1 550 Ccnb3 cyclin B1 NM_172301 mouse VB1-10108 TYPE1 550 Ccnd1 cyclin D1 (PRAD1: parathyroid adenomNM_053056 human VA4-10397 TYPE4 488 Ccnd1 Cyclin D1 NM_171992 rat VC6-10471 TYPE6 650 Ccnd2 cyclin D2 NM_009829 mouse VB1-10378 TYPE1 550 Ccndbp1 cyclin D-type binding-protein 1 NM_012142 human VA10-10775 TYPE10 740 Ccr2 chemokine (C-C motif) receptor 2 NM_021866 rat VC1-11039 TYPE1 550 Ccr3 Chemokine (C-C motif) receptor 2 NM_000647 human VA1-11042 TYPE1 550 CD207 CD207 antigen, langerin NM_015717 human VA1-10268 TYPE1 550 CD274 CD274 antigen NM_021893 mouse VB6-10662 TYPE6 650 CD38 CD38 antigen NM_007646 mouse VB4-11157 TYPE4 488 CD4 CD4 antigen NM_013488 mouse VB1-10236 TYPE1 550 CD44 CD44 antigen (homing function and In NM_000610 human VA1-10360 TYPE1 550 CD80 CD80 antigen (CD28 antigen ligand 1, NM_005191 human VA1-10270 TYPE1 550 CD81 CD81 antigen NM_133655 mouse VB6-10315 TYPE6 650 Cdh1 cadherin 1 NM_009864 mouse VB6-10969 TYPE6 650 Cdh1 cadherin
Load more

Recommended publications
  • Supporting Information
    Supporting Information Koyanagi et al. 10.1073/pnas.0806215105 SI Materials and Methods CNGB, NM࿝137763; human CNGB1, NM࿝001297; human ࿝ Amino Acid Sequences. The accession numbers of amino acid CNGB3, NM 019098; box jellyfish CNG, AB435552; fruit fly ࿝ ࿝ sequences used for analyses are as follows: Box jellyfish opsin, CNG4, NM 167441; fruit fly CNG3, NM 137871; human ࿝ ࿝ AB435549; sea anemone opsin, BR000662; hydra opsin, Con- CNGA4, NM 001037329; fruit fly CNGA, NM 057768; human CNGA1, NM࿝000087; human CNGA2, NM࿝005140; human tig39347:487820–488855 (http://hydrazome.metazome.net); hy- ࿝ drozaon jellyfish opsin, AB332435; human encephalopsin, CNGA3, NM 001298. AF140242; ragworm c-opsin, AY692353; human rhodopsin, Western Blot Analysis. The proteins extracted from half a rhopalia U49742; human blue, M13299; human red, Z68193; lamprey were separated by 12% SDS/PAGE, transferred onto a PVDF parapinopsin, AB116380; lizard parietopsin, DQ100320; am- membrane, and incubated with 1:500 diluted anti-box jellyfish phioxus peropsin, AB050610; human peropsin, AF012270; hu- opsin antiserum. Visualization was carried out by the ABC man rgr, U15790; squid retinochrome, X57143; human melan- method (Vectastain) and by staining with 3,3Ј-diaminobenzidine opsin, AF147788; amphioxus melanopsin, AB205400; squid (Sigma). rhodopsin, X70498; fruit fly Rh1, K02315; human neuropsin, AY377391; amphioxus rhodopsin, AB050606; scallop Go- In Situ Hybridization. Digoxigenin-labeled antisense and sense RNA rhodopsin, AB006455; human muscarinic acetylcholine receptor probes for the box jellyfish opsin were synthesized by using the DIG M1 (CHRM1), NM࿝000738; human melatonin receptor 1A RNA labeling kit (Roche). Sections were pretreated with protein- (MTNR1A), NM࿝005958; Arabidopsis AKT1, U06745; Arabi- ase K and hybridized with each RNA probe.
    [Show full text]
  • The G Protein-Coupled Receptor Subset of the Dog Genome Is More Similar
    BMC Genomics BioMed Central Research article Open Access The G protein-coupled receptor subset of the dog genome is more similar to that in humans than rodents Tatjana Haitina1, Robert Fredriksson1, Steven M Foord2, Helgi B Schiöth*1 and David E Gloriam*2 Address: 1Department of Neuroscience, Functional Pharmacology, Uppsala University, BMC, Box 593, 751 24, Uppsala, Sweden and 2GlaxoSmithKline Pharmaceuticals, New Frontiers Science Park, 3rd Avenue, Harlow CM19 5AW, UK Email: Tatjana Haitina - [email protected]; Robert Fredriksson - [email protected]; Steven M Foord - [email protected]; Helgi B Schiöth* - [email protected]; David E Gloriam* - [email protected] * Corresponding authors Published: 15 January 2009 Received: 20 August 2008 Accepted: 15 January 2009 BMC Genomics 2009, 10:24 doi:10.1186/1471-2164-10-24 This article is available from: http://www.biomedcentral.com/1471-2164/10/24 © 2009 Haitina et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The dog is an important model organism and it is considered to be closer to humans than rodents regarding metabolism and responses to drugs. The close relationship between humans and dogs over many centuries has lead to the diversity of the canine species, important genetic discoveries and an appreciation of the effects of old age in another species. The superfamily of G protein-coupled receptors (GPCRs) is one of the largest gene families in most mammals and the most exploited in terms of drug discovery.
    [Show full text]
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Multifaceted Physiological Roles of Adiponectin in Inflammation And
    International Journal of Molecular Sciences Review Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases Hyung Muk Choi 1, Hari Madhuri Doss 1,2 and Kyoung Soo Kim 1,2,* 1 Department of Clinical Pharmacology and Therapeutics, Kyung Hee University School of Medicine, Seoul 02447, Korea; [email protected] (H.M.C.); [email protected] (H.M.D.) 2 East-West Bone & Joint Disease Research Institute, Kyung Hee University Hospital at Gangdong, Gandong-gu, Seoul 02447, Korea * Correspondence: [email protected]; Tel.: +82-2-961-9619 Received: 3 January 2020; Accepted: 10 February 2020; Published: 12 February 2020 Abstract: Adiponectin is the richest adipokine in human plasma, and it is mainly secreted from white adipose tissue. Adiponectin circulates in blood as high-molecular, middle-molecular, and low-molecular weight isoforms. Numerous studies have demonstrated its insulin-sensitizing, anti-atherogenic, and anti-inflammatory effects. Additionally, decreased serum levels of adiponectin is associated with chronic inflammation of metabolic disorders including Type 2 diabetes, obesity, and atherosclerosis. However, recent studies showed that adiponectin could have pro-inflammatory roles in patients with autoimmune diseases. In particular, its high serum level was positively associated with inflammation severity and pathological progression in rheumatoid arthritis, chronic kidney disease, and inflammatory bowel disease. Thus, adiponectin seems to have both pro-inflammatory and anti-inflammatory effects. This indirectly indicates that adiponectin has different physiological roles according to an isoform and effector tissue. Knowledge on the specific functions of isoforms would help develop potential anti-inflammatory therapeutics to target specific adiponectin isoforms against metabolic disorders and autoimmune diseases.
    [Show full text]
  • Neurotensin Activates Gabaergic Interneurons in the Prefrontal Cortex
    The Journal of Neuroscience, February 16, 2005 • 25(7):1629–1636 • 1629 Behavioral/Systems/Cognitive Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex Kimberly A. Petrie,1 Dennis Schmidt,1 Michael Bubser,1 Jim Fadel,1 Robert E. Carraway,2 and Ariel Y. Deutch1 1Departments of Pharmacology and Psychiatry, Vanderbilt University Medical Center, Nashville, Tennessee 37212, and 2Department of Physiology, University of Massachusetts Medical Center, Worcester, Massachusetts 01655 Converging data suggest a dysfunction of prefrontal cortical GABAergic interneurons in schizophrenia. Morphological and physiological studies indicate that cortical GABA cells are modulated by a variety of afferents. The peptide transmitter neurotensin may be one such modulator of interneurons. In the rat prefrontal cortex (PFC), neurotensin is exclusively localized to dopamine axons and has been suggested to be decreased in schizophrenia. However, the effects of neurotensin on cortical interneurons are poorly understood. We used in vivo microdialysis in freely moving rats to assess whether neurotensin regulates PFC GABAergic interneurons. Intra-PFC administra- tion of neurotensin concentration-dependently increased extracellular GABA levels; this effect was impulse dependent, being blocked by treatment with tetrodotoxin. The ability of neurotensin to increase GABA levels in the PFC was also blocked by pretreatment with 2-[1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)pyrazole-3-yl)carbonylamino]tricyclo(3.3.1.1.3.7)decan-2-carboxylic acid (SR48692), a high-affinity neurotensin receptor 1 (NTR1) antagonist. This finding is consistent with our observation that NTR1 was localized to GABAergic interneurons in the PFC, particularly parvalbumin-containing interneurons. Because neurotensin is exclusively localized to dopamine axons in the PFC, we also determined whether neurotensin plays a role in the ability of dopamine agonists to increase extracellular GABA levels.
    [Show full text]
  • Genetic Basis of Idiopathic Scoliosis
    Research & Review: Management of Cardiovascular and Orthopedic Complications Volume 1 Issue 1 Genetic Basis of Idiopathic Scoliosis S. Sreeremya Assistant Professor, Department of Biotechnology, Sree Narayana Guru College, Coimbatore, Tamil Nadu, India Email: [email protected] Abstract Idiopathic scoliosis (IS), the most usual spinal deformity, affects otherwise healthy children and adolescents during growth. The etiology is still not quiet understood, although genetic factors are believed to be important. This review corroborates the understanding of IS as a complex disease with a polygenic background. Presumably IS can be typically due to a spectrum of genetic risk variants, ranging from very rare or even private to very common. The most promising candidate genes are highlighted. Keywords: Idiopathic scoliosis, Genetics, Pathogenesis, Heredity INTRODUCTION marked by phenotypic complexity Idiopathic scoliosis (IS), the most general (variations in curve morphology and form of spinal deformity, affects otherwise magnitude, age of onset, rate of healthy children and adolescents during progression), and a prognosis mainly growth (Fig: 1). It usually presents as a rib ranging from increase in curve magnitude, hump visible at forward bending, together to stabilization, or to resolution with with unlevelled shoulders and an growth [5]. Genetic factors are known to asymmetrical waist [1]. According to play a pivotal role, as observed in twin Cobb, the diagnosis is specifically studies and their observation and singleton confirmed by a standing spinal radiograph multigenerational families [6]. A recent showing a lateral curvature of the spine research of monozygotic and dizygotic exceeding 10° [2]. A main concern in IS is twins from the Swedish twin registry the absence of reliable means by which to estimated that overall genetic effects predict risk of progression, leading to accounted for 39 % of the observed frequent follow-ups, radiographs, and phenotypic variance, leaving the remaining potentially unnecessary brace treatments.
    [Show full text]
  • Adiporon, an Orally Active, Synthetic Agonist of Adipor1 and Adipor2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice
    molecules Article AdipoRon, an Orally Active, Synthetic Agonist of AdipoR1 and AdipoR2 Receptors Has Gastroprotective Effect in Experimentally Induced Gastric Ulcers in Mice Hubert Zatorski 1,2, Maciej Salaga 1 , Marta Zieli ´nska 1, Kinga Majchrzak 1, Agata Binienda 1 , Radzisław Kordek 3, Ewa Małecka-Panas 2 and Jakub Fichna 1,4,* 1 Department of Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland; [email protected] (H.Z.); [email protected] (M.S.); [email protected] (M.Z.); [email protected] (K.M.); [email protected] (A.B.) 2 Department of Digestive Tract Diseases, Medical University of Lodz, 93-281 Lodz, Poland; [email protected] 3 Department of Pathology, Medical University of Lodz, 92-215 Lodz, Poland; [email protected] 4 Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland * Correspondence: jakub.fi[email protected]; Tel.: +48-42-272-57-07 Citation: Zatorski, H.; Salaga, M.; Abstract: Introduction: Adiponectin is a hormone secreted by adipocytes, which exhibits insulin- Zieli´nska,M.; Majchrzak, K.; sensitizing and anti-inflammatory properties and acts through adiponectin receptors: AdipoR1 and Binienda, A.; Kordek, R.; AdipoR2. The aim of the study was to evaluate whether activation of adiponectin receptors AdipoR1 Małecka-Panas, E.; Fichna, J. and AdipoR2 with an orally active agonist AdipoRon has gastroprotective effect and to investigate AdipoRon, an Orally Active, the possible underlying mechanism. Methods: We used two well-established mouse models of Synthetic Agonist of AdipoR1 and gastric ulcer (GU) induced by oral administration of EtOH (80% solution in water) or diclofenac AdipoR2 Receptors Has (30 mg/kg, p.o.).
    [Show full text]
  • Peptide, Peptidomimetic and Small Molecule Based Ligands Targeting Melanocortin Receptor System
    PEPTIDE, PEPTIDOMIMETIC AND SMALL MOLECULE BASED LIGANDS TARGETING MELANOCORTIN RECEPTOR SYSTEM By ALEKSANDAR TODOROVIC A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY UNIVERSITY OF FLORIDA 2006 Copyright 2006 by Aleksandar Todorovic This document is dedicated to my family for everlasting support and selfless encouragement. ACKNOWLEDGMENTS I would like to thank and sincerely express my appreciation to all members, former and past, of Haskell-Luevano research group. First of all, I would like to express my greatest satisfaction by working with my mentor, Dr. Carrie Haskell-Luevano, whose guidance, expertise and dedication to research helped me reaching the point where I will continue the science path. Secondly, I would like to thank Dr. Ryan Holder who has taught me the principles of solid phase synthesis and initial strategies for the compounds design. I would like to thank Mr. Jim Rocca for the help and all necessary theoretical background required to perform proton 1-D NMR. In addition, I would like to thank Dr. Zalfa Abdel-Malek from the University of Cincinnati for the collaboration on the tyrosinase study project. Also, I would like to thank the American Heart Association for the Predoctoral fellowship that supported my research from 2004-2006. The special dedication and thankfulness go to my fellow graduate students within the lab and the department. iv TABLE OF CONTENTS page ACKNOWLEDGMENTS ................................................................................................
    [Show full text]
  • Expression of Melatonin Receptors 1A/1B, Calmodulin and Estrogen Receptor 2 in Deep Paravertebral Muscles Revisited
    MOLECULAR MEDICINE REPORTS 14: 5719-5724, 2016 Etiopathogenesis of adolescent idiopathic scoliosis: Expression of melatonin receptors 1A/1B, calmodulin and estrogen receptor 2 in deep paravertebral muscles revisited JOSEF ZAMECNIK1*, LENKA KRSKOVA1*, JAROMIR HACEK1, IVANA STETKAROVA2 and MARTIN KRBEC3 1Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, 15006 Prague; 2Department of Neurology, Charles University; 3Department of Orthopedics and Traumatology, 3rd Faculty of Medicine, Charles University in Prague and University Hospital Královské Vinohrady, 10034 Prague, Czech Republic Received October 28, 2015; Accepted October 11, 2016 DOI: 10.3892/mmr.2016.5927 Abstract. The pathogenesis of adolescent idiopathic scoliosis addition, no difference in expression was detected between the (AIS), including the associated local changes in deep para- patients with AIS and the controls. With regards to MTNR1A vertebral muscles, is poorly understood. The asymmetric and MTNR1B, their expression was very weak in paravertebral expression of several molecules involved in the melatonin muscles, and in the majority of cases their expression could signaling pathway, including melatonin receptors 1A/1B not be detected by repeated RT-qPCR analysis. Therefore, (MTNR1A/MTNR1B), estrogen receptor 2 (ESR2) and these data do not support the previously suggested role of the calmodulin (CALM1), has previously been suggested to be asymmetric expression of molecules involved in the melatonin associated with AIS. However, this hypothesis is based on signaling pathway in deep paravertebral muscles in the patho- single studies in which the data were obtained by different genesis of AIS. methodological approaches. Therefore, to evaluate the symmetry of the mRNA expression levels of these molecules, Introduction 18 patients with AIS and 10 non-scoliotic controls were enrolled in the present study.
    [Show full text]
  • Supporting Online Material
    1 2 3 4 5 6 7 Supplementary Information for 8 9 Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic 10 retinopathy 11 12 *Samuel A. Mills, *Andrew I. Jobling, *Michael A. Dixon, Bang V. Bui, Kirstan A. Vessey, Joanna A. Phipps, 13 Ursula Greferath, Gene Venables, Vickie H.Y. Wong, Connie H.Y. Wong, Zheng He, Flora Hui, James C. 14 Young, Josh Tonc, Elena Ivanova, Botir T. Sagdullaev, Erica L. Fletcher 15 * Joint first authors 16 17 Corresponding author: 18 Prof. Erica L. Fletcher. Department of Anatomy & Neuroscience. The University of Melbourne, Grattan St, 19 Parkville 3010, Victoria, Australia. 20 Email: [email protected] ; Tel: +61-3-8344-3218; Fax: +61-3-9347-5219 21 22 This PDF file includes: 23 24 Supplementary text 25 Figures S1 to S10 26 Tables S1 to S7 27 Legends for Movies S1 to S2 28 SI References 29 30 Other supplementary materials for this manuscript include the following: 31 32 Movies S1 to S2 33 34 35 36 1 1 Supplementary Information Text 2 Materials and Methods 3 Microglial process movement on retinal vessels 4 Dark agouti rats were anaesthetized, injected intraperitoneally with rhodamine B (Sigma-Aldrich) to label blood 5 vessels and retinal explants established as described in the main text. Retinal microglia were labelled with Iba-1 6 and imaging performed on an inverted confocal microscope (Leica SP5). Baseline images were taken for 10 7 minutes, followed by the addition of PBS (10 minutes) and then either fractalkine or fractalkine + candesartan 8 (10 minutes) using concentrations outlined in the main text.
    [Show full text]
  • Supplementary Table 3 Complete List of RNA-Sequencing Analysis of Gene Expression Changed by ≥ Tenfold Between Xenograft and Cells Cultured in 10%O2
    Supplementary Table 3 Complete list of RNA-Sequencing analysis of gene expression changed by ≥ tenfold between xenograft and cells cultured in 10%O2 Expr Log2 Ratio Symbol Entrez Gene Name (culture/xenograft) -7.182 PGM5 phosphoglucomutase 5 -6.883 GPBAR1 G protein-coupled bile acid receptor 1 -6.683 CPVL carboxypeptidase, vitellogenic like -6.398 MTMR9LP myotubularin related protein 9-like, pseudogene -6.131 SCN7A sodium voltage-gated channel alpha subunit 7 -6.115 POPDC2 popeye domain containing 2 -6.014 LGI1 leucine rich glioma inactivated 1 -5.86 SCN1A sodium voltage-gated channel alpha subunit 1 -5.713 C6 complement C6 -5.365 ANGPTL1 angiopoietin like 1 -5.327 TNN tenascin N -5.228 DHRS2 dehydrogenase/reductase 2 leucine rich repeat and fibronectin type III domain -5.115 LRFN2 containing 2 -5.076 FOXO6 forkhead box O6 -5.035 ETNPPL ethanolamine-phosphate phospho-lyase -4.993 MYO15A myosin XVA -4.972 IGF1 insulin like growth factor 1 -4.956 DLG2 discs large MAGUK scaffold protein 2 -4.86 SCML4 sex comb on midleg like 4 (Drosophila) Src homology 2 domain containing transforming -4.816 SHD protein D -4.764 PLP1 proteolipid protein 1 -4.764 TSPAN32 tetraspanin 32 -4.713 N4BP3 NEDD4 binding protein 3 -4.705 MYOC myocilin -4.646 CLEC3B C-type lectin domain family 3 member B -4.646 C7 complement C7 -4.62 TGM2 transglutaminase 2 -4.562 COL9A1 collagen type IX alpha 1 chain -4.55 SOSTDC1 sclerostin domain containing 1 -4.55 OGN osteoglycin -4.505 DAPL1 death associated protein like 1 -4.491 C10orf105 chromosome 10 open reading frame 105 -4.491
    [Show full text]
  • Structure-Based Redesigning of Pentoxifylline Analogs Against
    www.nature.com/scientificreports OPEN Structure‑based redesigning of pentoxifylline analogs against selective phosphodiesterases to modulate sperm functional competence for assisted reproductive technologies Mutyala Satish1,5, Sandhya Kumari2,5, Waghela Deeksha1, Suman Abhishek1, Kulhar Nitin1, Satish Kumar Adiga2, Padmaraj Hegde3, Jagadeesh Prasad Dasappa4, Guruprasad Kalthur2* & Eerappa Rajakumara1* Phosphodiesterase (PDE) inhibitors, such as pentoxifylline (PTX), are used as pharmacological agents to enhance sperm motility in assisted reproductive technology (ART), mainly to aid the selection of viable sperm in asthenozoospermic ejaculates and testicular spermatozoa, prior to intracytoplasmic sperm injection (ICSI). However, PTX is reported to induce premature acrosome reaction (AR) and, exert toxic efects on oocyte function and early embryo development. Additionally, in vitro binding studies as well as computational binding free energy (ΔGbind) suggest that PTX exhibits weak binding to sperm PDEs, indicating room for improvement. Aiming to reduce the adverse efects and to enhance the sperm motility, we designed and studied PTX analogues. Using structure‑guided in silico approach and by considering the physico‑chemical properties of the binding pocket of the PDEs, designed analogues of PTX. In silico assessments indicated that PTX analogues bind more tightly to PDEs and form stable complexes. Particularly, ex vivo evaluation of sperm treated with one of the PTX analogues (PTXm‑1), showed comparable benefcial efect at much lower concentration—slower
    [Show full text]